0001179110-17-002810.txt : 20170221 0001179110-17-002810.hdr.sgml : 20170221 20170221175142 ACCESSION NUMBER: 0001179110-17-002810 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170216 FILED AS OF DATE: 20170221 DATE AS OF CHANGE: 20170221 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AbbVie Inc. CENTRAL INDEX KEY: 0001551152 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320375147 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 BUSINESS PHONE: (847) 932-7900 MAIL ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HURWICH THOMAS A. CENTRAL INDEX KEY: 0001563573 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35565 FILM NUMBER: 17626300 MAIL ADDRESS: STREET 1: 1 N. WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 4 1 edgar.xml FORM 4 - X0306 4 2017-02-16 0 0001551152 AbbVie Inc. ABBV 0001563573 HURWICH THOMAS A. 1 N. WAUKEGAN ROAD NORTH CHICAGO IL 60064 0 1 0 0 VP, Controller Common stock, $0.01 par value 2017-02-16 4 A 0 5612 0 A 67061 D Common stock, $0.01 par value 2017-02-16 4 A 0 2526 0 A 69587 D Common stock, $0.01 par value 447 I Profit sharing trust Common stock, $0.01 par value 274 I By spouse in IRA Option (right to buy) 61.36 2017-02-16 4 A 0 13050 0 A 2018-02-16 2027-02-15 Common shares 13050 13050 D Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 18, 2016. The award is subject to performance-vesting restrictions based on adjusted earnings per share and relative total shareholder return measures. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2017. Represents shares of AbbVie common stock issued under a performance-vested restricted stock unit award granted to the reporting person on February 18, 2016. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2017. Balance in the AbbVie Savings Program as of February 16, 2017. The reporting person disclaims beneficial ownership of all securities held by his spouse. Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exercisable in annual increments of 4,350 on 02/16/2018, 4,350 on 02/16/2019, and 4,350 on 02/16/2020. Steven L. Scrogham, attorney-in-fact for Thomas A. Hurwich 2017-02-21